The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that. The post GSK’s share price looks a steal to me ...
A devastating 77-magnitude earthquake struck Myanmar unleashing energy equal to 334 atomic bombs Experts warn of lasting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback